Trump Just Said “Biotechnology” for the First Time in 353 Days as President
Biotechnology is a $350 billion-a-year industry for the U.S., but until now, President Donald J. Trump has never mentioned it.
Why you should care: Trump hasn’t ever said the words “CRISPR,” “embryo editing,” “eugenics,” or “gene therapy,” either. Biologists are understandably anxious about what he thinks.
What he’s said now: “We are streamlining regulations that have blocked cutting-edge biotechnology, setting free our farmers to innovate, thrive, and to grow,” Trump told a meeting of the American Farm Bureau Federation in Nashville, Tennessee, on January 8. (He added, “Oh, are you happy you voted for me. You are so lucky that I gave you that privilege.”)
He’s pro-GMO? Sounds like it. KFC-loving Trump may have been referring to how, in November, his administration scrapped USDA rules that would have regulated plants created through gene-editing tools like CRISPR.
In an e-mail, a spokesperson for the Biotechnology Innovation Organization, the industry’s trade group, confirmed it was the first time Trump has uttered the word as president.
Deep Dive
Biotechnology and health
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
An AI-driven “factory of drugs” claims to have hit a big milestone
Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology
The quest to legitimize longevity medicine
Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.
There is a new most expensive drug in the world. Price tag: $4.25 million
But will the latest gene therapy suffer the curse of the costliest drug?
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.